Non Opioid Pain Patch Market: By Drug Class, By Distribution Channel, By Treatment Centers, By Route of Administration, and Region Forecast 2019-2030
Non Opioid Pain Patch Market size was valued at US$ 623.13 million in 2023 and is expected to reach US$ 1279.02 million by 2030, at a CAGR of 14.6% from 2024-2030. Pain is a symptom, generally resulting from any infection, injury disease, or disorder. Several people around the world suffer from different types of pain such as chronic pain, acute pain, lower back pain, neck pain, headache, etc. Chronic pain usually lasts longer and intense. Pain is treated through various treatments using, drugs, physical therapy, and others. Nonopioid pain patches are a kind of treatment for the pain. Opioid medicine is used by a huge number of people as a pain reliever.
According to the United Nations Office on Drugs and Crime's figures, nearly 26.4 to 36 million persons worldwide abused opioids in 2012. There has been a rise in demand for non-opioid therapies due to an increase in the rate of addiction and severe side effects associated with long-term use of opioid medications. Non-opioid medicines have analgesic, antipyretic, and anti-inflammatory effects. These drugs work by blocking the enzyme cyclooxygenase at the site of injury, which then prevents the generation of prostaglandins, reducing the release of pain mediators in the peripheral nervous system. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Non Market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition.
Study Period
2024-2030Base Year
2023CAGR
14.6%Largest Market
North-AmericaFastest Growing Market
Europe
With the rise in the number of people suffering from pain disorders, there is a greater demand for new ways to pain management. In addition, rising treatment expenses and an increase in the number of people suffering from chronic and acute pain are two important drivers driving market expansion. Furthermore, as people become more aware of the negative consequences of frequent opioid usage, demand for non-opioid medications has increased. Increased R&D to produce non-opioid medications in response to an increase in opioid medication addiction has fueled market expansion. However, negative concerns associated with long-term or excessive use of non-opioid medications, such as liver or kidney damage, may limit market expansion.
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 623.13 million |
|
Market Size in 2030 |
US$ 1279.02 million |
|
Market CAGR |
14.6% |
|
By Type |
|
|
By Distribution Channel |
|
Download Free Sample Report
The global infectious disease therapeutics market size valued at US$ 623.13 million in 2023 and is projected to reach US$ 1279.02 million by 2030, at a CAGR of 14.6%.
The market key players are: Omeros Camurus Orexo MediciNova Teva Pharmaceuticals Hikma Pharmaceuticals Reckitt Benckiser Pharmaceuticals, Inc. Mylan Dr. Reddy's Laboratories Addinex Technologies, Inc. Indivior Alkermes Titan Pharmaceuticals
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Opioids Market Introduction |
| 2.1. Global Opioids Market Taxonomy |
| 2.2. Global Opioids Market Definitions |
| 2.2.1. By Drug Class |
| 2.2.2. By Distribution Channel |
| 2.2.3. By Treatment Centers |
| 2.2.4. By Route of Administration |
| 2.2.5. By Region |
| 3. Global Opioids Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Opioids Market Dynamic Factors - Impact Analysis |
| 3.6. Impact of COVID 19 on The Market |
| 3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic |
| 3.8. Mapping Market Players Activities |
| 3.9. Recent Key Developments |
| 3.10. Financial Status of the Market Players |
| 3.11. Recent Acquisitions, Collaborations, and Mergers |
| 4. Global Opioids Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Opioids Market Forecast, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.1. Naloxone |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Buprenorphine |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Methadone |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Opioids Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.1. Retail Pharmacies |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospitals |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Rehabilitation Centers |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Market Opportunity Analysis Global Opioids Market Forecast, By Treatment Centers, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 7.1. Residential Treatment Centers |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Outpatient Treatment Centers |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Inpatient Treatment Centers |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Market Opportunity Analysis Global Opioids Market Forecast, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 8.1. Oral |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Parental |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9. Global Opioids Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Opioids Market - Opportunity Analysis Index, By Drug Class, Distribution Channel, Treatment Centers, Route of Administration, and Region, 2024 - 2030 |
| 10. North America Opioids Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 10.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 10.1.1. Naloxone |
| 10.1.2. Buprenorphine |
| 10.1.3. Methadone |
| 10.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Retail Pharmacies |
| 10.2.2. Hospitals |
| 10.2.3. Rehabilitation |
| 10.3. Treatment Centers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Residential Treatment Centers |
| 10.3.2. Outpatient Treatment Centers |
| 10.3.3. Inpatient Treatment Centers |
| 10.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Oral |
| 10.4.2. Parental |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. U.S. |
| 10.5.2. Canada |
| 10.6. North America Opioids Market - Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2024 - 2030 |
| 10.7. North America Opioids Market Dynamics Trends |
| 11. Europe Opioids Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 11.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 11.1.1. Naloxone |
| 11.1.2. Buprenorphine |
| 11.1.3. Methadone |
| 11.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Retail Pharmacies |
| 11.2.2. Hospitals |
| 11.2.3. Rehabilitation |
| 11.3. Treatment Centers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Residential Treatment Centers |
| 11.3.2. Outpatient Treatment Centers |
| 11.3.3. Inpatient Treatment Centers |
| 11.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Oral |
| 11.4.2. Parental |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Italy |
| 11.5.5. Spain |
| 11.5.6. Rest of Europe |
| 11.6. Europe Opioids Market - Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2024 - 2030 |
| 11.7. Europe Opioids Market Dynamics Trends |
| 12. Asia-Pacific Opioids Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 12.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 12.1.1. Naloxone |
| 12.1.2. Buprenorphine |
| 12.1.3. Methadone |
| 12.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Retail Pharmacies |
| 12.2.2. Hospitals |
| 12.2.3. Rehabilitation |
| 12.3. Treatment Centers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Residential Treatment Centers |
| 12.3.2. Outpatient Treatment Centers |
| 12.3.3. Inpatient Treatment Centers |
| 12.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Oral |
| 12.4.2. Parental |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Opioids Market - Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2024 - 2030 |
| 12.7. Asia-Pacific Opioids Market Dynamics Trends |
| 13. Latin America Opioids Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 13.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 13.1.1. Naloxone |
| 13.1.2. Buprenorphine |
| 13.1.3. Methadone |
| 13.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Retail Pharmacies |
| 13.2.2. Hospitals |
| 13.2.3. Rehabilitation |
| 13.3. Treatment Centers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Residential Treatment Centers |
| 13.3.2. Outpatient Treatment Centers |
| 13.3.3. Inpatient Treatment Centers |
| 13.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Oral |
| 13.4.2. Parental |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Argentina |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Opioids Market - Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2024 - 2030 |
| 13.7. Latin America Opioids Market Dynamics Trends |
| 14. Middle East and Africa Opioids Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 14.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 14.1.1. Naloxone |
| 14.1.2. Buprenorphine |
| 14.1.3. Methadone |
| 14.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Retail Pharmacies |
| 14.2.2. Hospitals |
| 14.2.3. Rehabilitation |
| 14.3. Treatment Centers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1. Residential Treatment Centers |
| 14.3.2. Outpatient Treatment Centers |
| 14.3.3. Inpatient Treatment Centers |
| 14.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1. Oral |
| 14.4.2. Parental |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Saudi Arabia |
| 14.5.2. GCC Countries |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA Opioids Market - Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2024 - 2030 |
| 14.7. MEA Opioids Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Drug Class Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Omeros |
| 15.2.2. Camurus |
| 15.2.3. Orexo |
| 15.2.4. MediciNova |
| 15.2.5. Teva Pharmaceuticals |
| 15.2.6. Â Hikma Pharmaceuticals |
| 15.2.7. Reckitt Benckiser Pharmaceuticals, Inc. |
| 15.2.8. Mylan |
| 15.2.9. Dr. Reddy's Laboratories |
| 15.2.10. Addinex Technologies, Inc. |
| 15.2.11. Indivior |
| 15.2.12. Alkermes |
| 15.2.13. Titan Pharmaceuticals |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
